Minnelide, a Potent Chemotherapeutic Agent Against Pancreatic Cancer

被引：0
|
作者：
Sangwan, V. [1 ]
Chugh, R. K. [1 ]
Johnson, D. M. [1 ]
Banerjee, S. [1 ]
Dudeja, V. [1 ]
Mujumdar, N. [1 ]
Mackenzie, T. N. [1 ]
Vickers, S. M. [1 ]
Saluja, A. K. [1 ]
机构：
[1] Univ Minnesota, Div Basic & Translat Res, Dept Surg, Minneapolis, MN 55455 USA
来源：
PANCREAS | 2011年 / 40卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1352 / 1352
页数：1
相关论文
共 50 条
  • [21] A Ru(II) Polypyridyl Complex Bearing Bathocuproine Ligand is a Potent Chemotherapeutic Agent Against Chemically Induced Skin Cancer Model
    Elias, Maria George
    Mehanna, Stephanie
    Nasser, Selim
    Daher, Costantine F.
    Khnayzer, Rony S.
    ADVANCED THERAPEUTICS, 2024, 7 (12)
  • [22] Chemotherapeutic advances in pancreatic cancer
    Jordan D. Berlin
    Mace L. Rothenberg
    Current Oncology Reports, 2003, 5 (3) : 219 - 226
  • [23] Novel disubstituted chrysene as a potent agent against colon cancer
    Banik, Bimal K.
    Basu, Manas K.
    Becker, Fredrick F.
    ONCOLOGY LETTERS, 2010, 1 (06) : 1033 - 1035
  • [24] Synthesis of new tricyclic thiolactams as potent antitumor agent for pancreatic cancer
    Okada, Takuya
    Minehira, Daisuke
    Takada, Minetatsu
    Urata, Hirokazu
    Kato, Atsushi
    Adachi, Isao
    Kurashima, Yukiko
    Kaji, Satoshi
    Ogura, Tsutomu
    Chiba, Shigeki
    Esumi, Hiroyasu
    Toyooka, Naoki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (11) : 2577 - 2579
  • [25] Imperatorin as a Promising Chemotherapeutic Agent against Human Larynx Cancer and Rhabdomyosarcoma Cells
    Grabarska, Aneta
    Skalicka-Wozniak, Krystyna
    Kielbus, Michal
    Dmoszynska-Graniczka, Magdalena
    Miziak, Paulina
    Szumilo, Justyna
    Nowosadzka, Ewa
    Kowalczuk, Krystyna
    Khalifa, Sherief
    Smok-Kalwat, Jolanta
    Klatka, Janusz
    Kupisz, Krzysztof
    Polberg, Krzysztof
    Rivero-Muller, Adolfo
    Stepulak, Andrzej
    MOLECULES, 2020, 25 (09):
  • [26] Minnelide Causes Stromal Lysis and Improves Drug Delivery in Pancreatic Cancer
    Banerjee, S.
    Modi, S.
    Majumdar, K.
    Dudeja, V.
    Vickers, S. M.
    Saluja, A.
    PANCREAS, 2014, 43 (08) : 1343 - 1343
  • [27] Nrf2 in Pancreatic Cancer Chemotherapy Response and the Use of Brusatol as a Chemotherapeutic Agent
    Williams, D.
    Gana, T.
    Sivapalan, L.
    Butler, O.
    Jackson, R.
    Perez-Mancera, P.
    Barrera-Briceno, L.
    Copple, I.
    Cox, T.
    Goldring, C.
    Halloran, C. M.
    Ghaneh, P.
    Palmer, D.
    Strobel, O.
    Greenhalf, W.
    Neoptolemos, J. P.
    Costello, E.
    PANCREAS, 2017, 46 (10) : 1443 - 1443
  • [28] Selenium nanoparticles: A potent chemotherapeutic agent and an elucidation of its mechanism
    Menon, Soumya
    Devi, Shrudhi K. S.
    Santhiya, R.
    Rajeshkumar, S.
    Kumar, Venkat S.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 170 : 280 - 292
  • [29] Vanadium: A possible chemotherapeutic agent against astrocytomas
    Olopade, James
    MadhanKumar, Achuthamangalam
    Das, Arunangshu
    Liu, Xiaoli
    Todorich, Bozho
    Liang, John
    Slagle-Webb, Becky
    Connor, James
    CANCER RESEARCH, 2009, 69
  • [30] 2,4-Dithiothymine as a Potent UVA Chemotherapeutic Agent
    Pollum, Marvin
    Jockusch, Steffen
    Crespo-Hernandez, Carlos E.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (52) : 17930 - 17933
12345